
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has demonstrated a robust financial performance, highlighted by a recent quarterly dividend increase to $1.25, reflecting a year-over-year growth of approximately 9%, supported by consistent free cash flow generation. The company experienced significant growth in its trading volumes, with notable advancements in Henry Hub Natural Gas futures and options, alongside impressive gains in both equity and crypto products, such as a nearly 307% year-over-year increase in crypto average daily volume. Additionally, sustained product innovation and heightened customer demand have driven an increase of around 2.8 million average daily volume, resulting in a revenue generation of approximately $254 million over the past five years, positioning CME Group favorably for continued growth into 2025.
Bears say
The CME Group is currently facing challenges, particularly in its agricultural commodities segment, where a decline in average daily volume was noted due to improved weather conditions in South America expected to yield record soybean production. In a downside scenario analysis, a projected 10% decrease in earnings per share for FY26, coupled with a 20x price-to-earnings multiple, suggests potential valuation risks for CME's stock. Furthermore, the market data and information services revenue, while slightly exceeding estimates, may not be sufficient to offset the overall pressures on open interest and trading volumes, which could deteriorate investor sentiment and financial stability for the company.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares